34 results
8-K
EX-99.1
GLYC
GlycoMimetics Inc
6 May 24
Results of Operations and Financial Condition
4:01pm
, GlycoMimetics had cash and cash equivalents of $31.3 million, compared to $41.8 million as of December 31, 2023.
R&D Expenses: The company’s research
8-K
EX-99.1
GLYC
GlycoMimetics Inc
27 Mar 24
GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Full Year 2023
9:00am
equivalents of $41.8 million, compared to $47.9 million as of December 31, 2022.
R&D Expenses: The company’s research and development expenses decreased
8-K
EX-99.1
GLYC
GlycoMimetics Inc
3 Nov 23
GlycoMimetics Reports Highlights and Financial Results for Third Quarter 2023
8:35am
to $47.9 million as of December 31, 2022.
R&D Expenses: The company’s research and development expenses increased to $5.3 million for the quarter ended
8-K
EX-99.1
GLYC
GlycoMimetics Inc
2 Aug 23
GlycoMimetics Reports Highlights and Financial Results for Second Quarter 2023
8:35am
position: As of June 30, 2023, GlycoMimetics had cash and cash equivalents of $58.0 million as compared to $47.9 million as of December 31, 2022.
R&D Expenses
8-K
EX-99.1
GLYC
GlycoMimetics Inc
3 May 23
GlycoMimetics Reports Highlights and Financial Results for First Quarter 2023
8:36am
existing ATM facility.
R&D Expenses: The Company’s research and development expenses decreased to $5.4 million for the quarter ended March 31, 2023
8-K
EX-99.1
ufzprjfquf53x2m0 wu5
9 Nov 22
GlycoMimetics Reports Highlights and Financial Results for Third Quarter 2022
8:15am
8-K
EX-99.1
wp44v
3 Aug 22
GlycoMimetics Reports Highlights and Financial Results for Second Quarter 2022
8:25am
8-K
EX-99.1
r1ic1mmag
28 Apr 22
GlycoMimetics Reports Highlights and Financial Results
8:30am
8-K
EX-99.1
t4f46mok2mjhyp
3 Mar 22
GlycoMimetics Reports Highlights and Financial Results
8:45am
8-K
EX-99.1
hwk7 04spbus8mgei
2 Nov 21
Glycomimetics Reports Highlights and Financial Results
8:15am
8-K
EX-99.1
m69tpa rwes
5 Aug 21
Glycomimetics Reports Highlights and Financial Results
8:01am
8-K
EX-99.1
h8xuyl
3 May 21
Glycomimetics Reports Highlights and Financial Results for Executive Management Team
9:00am
8-K
EX-99.1
917dt
2 Mar 21
Glycomimetics Reports Highlights and Financial Results for Fourth Quarter and Full Year 2020
4:16pm
8-K
EX-99.1
02qingkb89vehr
6 Nov 20
Glycomimetics Reports Highlights and Financial Results for
9:29am
8-K
EX-99.1
p95x7m
31 Jul 20
Glycomimetics Reports Highlights and Financial Results for
9:09am
8-K
EX-99.1
e57a7 fbe5zkycamup
1 May 20
Glycomimetics Reports Operational Highlights and Financial Results for
9:00am
8-K
EX-99.1
wq595
28 Feb 20
Glycomimetics Reports Highlights and Financial Results for Fourth Quarter and Year-end 2019
11:00am
8-K
EX-99.1
frswmbb7p7i ror
7 Nov 19
Glycomimetics Reports Third Quarter 2019 Financial
8:35am
8-K
EX-99.1
dfaex
1 Aug 19
Glycomimetics Reports Second Quarter 2019 Financial
8:35am